CD8A and neoplasm: In summary, the expression of TIGIT was increased after MWA, and the addition of anti-TIGIT therapy to MWA synergistically inhibited the growth of the tumor, increased the number of effector CD8+ T cells, and reversed the function of exhausted CD8+ T cells.